StockWatch
·

Gland Pharma Ltd

BSE: 543245

values in crores

Revenue & Profit Trend

in crores
RevenueExpenditureNet Profit
120.41550.42980.431.4KQ2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026

Margin Trend

percentage
OPM %NPM %
22.2829.0535.8142.58Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026
PeriodQ4 FY2026Q3 FY2026Q2 FY2026Q1 FY2026Q4 FY2025Q3 FY2025Q2 FY2025
INCOME
Revenue1.3K+7.1%1.2K+9.6%1.1K+3.4%1.0K+0.8%1.0K+1.9%1.0K-4.9%1.1K
Other Income106.36+76.7%60.21-27.1%82.59+50.9%54.74+25.2%43.72-32.8%65.06+12.6%57.80
Total Income1.4K+10.5%1.2K+7.0%1.2K+5.8%1.1K+1.8%1.1K-0.2%1.1K-4.0%1.1K
EXPENSES
Expenditure803.15+0.3%800.92+7.1%748.07+2.3%731.19+7.1%682.75+0.2%681.72-8.0%740.98
Tax144.35+38.0%104.61-1.9%106.68+14.6%93.13-8.1%101.32+2.3%99.01+0.9%98.11
PROFIT
PBT564.80+36.9%412.46+0.9%408.67+12.8%362.38-7.4%391.32-0.7%394.13+3.8%379.82
Net Profit420.45+36.6%307.85+1.9%302.00+12.2%269.26-7.2%290.00-1.7%295.12+4.8%281.71
KEY METRICS
OPM %40.24%+6.50pp33.74%-1.16pp34.90%+0.36pp34.54%-3.71pp38.25%+11.84pp26.41%+0.05pp26.36%
NPM %30.74%+5.87pp24.87%-1.24pp26.11%+1.49pp24.62%-2.38pp27.00%-0.43pp27.43%+2.30pp25.13%
EPS25.52+36.6%18.68+1.9%18.33+12.2%16.34-7.2%17.60-1.7%17.91+4.7%17.10

Corporate Events

DividendGLAND
2026
11Aug

₹20 / share

BSE Filing
Board MeetingGLAND
2024
4Nov

Board Meeting

Approval Of Unaudited Financial Results

BSE Filing
DividendGLAND
2024
16Aug

₹20 / share

BSE Filing
Board MeetingGLAND
2024
22May

Board Meeting

Consider and approve Audited Financial Results for the quart…

BSE Filing
Board MeetingGLAND
2024
14Feb

Board Meeting

Consider and approve Unaudited financial Results

BSE Filing
Board MeetingGLAND
2023
6Nov

Board Meeting

Consider and approve the Unaudited Standalone and Consolidat…

BSE Filing